Biotechnology for Healthy Ageing

Eligible expenses align with costs defined under the Lump Sum Model Grant Agreement (MGA) for Horizon Europe. Typically covers direct costs for research, personnel, equipment, consumables, and other activities specified in the proposal.

Excellence: Quality and pertinence of the project, clarity of objectives, innovation potential.

Impact: Contribution to healthy ageing, potential effects on healthcare and society, regulatory and market considerations.

Quality and Efficiency of Implementation: Work plan, management structures, resource allocation, feasibility of delivering expected outcomes.

Mid-caps and larger companies are not eligible for single beneficiary projects.

Projects focused on precision nutrition, novel ageing clocks, and wellness applications are excluded.

Reporting requirements as established in the Lump Sum Model Grant Agreement (MGA), likely including periodic and final reports on progress, milestone achievements, financial expenditures, and exploitation plans.

Proposals must be submitted online via the EU Funding & Tenders Portal and comply with admissibility and eligibility conditions.

Applications must include completed standard application forms, detailed description of project concept and objectives, budget tables, relevant annexes, and supporting documentation as specified in the call documents.

Complete proposal (Part A and Part B) including scientific rationale, objectives, methodology, work plan, and expected impact.

Consortium details and eligibility evidence if relevant.

Detailed budget breakdown in line with Lump Sum MGA requirements.

Supporting evidence for access to cohorts, models, or samples, where applicable.